Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00806715 · ClinicalTrials.gov registry record
Iron Overload in Stem Cell Transplant Recipients
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 38
- Enrollment target
NCT00806715: Completed study, sponsored by Boston Children's Hospital.
NCT00806715 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 38 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00806715 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
The goal of this study is to examine the impact of iron overload in patients undergoing a bone marrow transplant. We believe that the iron status in these patients is associated with complications for transplant survivors. We will examine the iron status in these patients by MRI and by screening for mutations in genes known to cause iron overload. We will also determine the levels of hepcidin (a hormone produced in the liver that appears to regulate iron homeostasis) from blood and urine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2007-02 |
| Est. Completion | 2010-10 |
What the finished NCT00806715 record still lists
NCT00806715 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 38 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00806715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00806715 about?
NCT00806715 is a clinical study titled "Iron Overload in Stem Cell Transplant Recipients". The goal of this study is to examine the impact of iron overload in patients undergoing a bone marrow transplant. We believe that the iron status in these patients is associated with complications for transplant survivors. We will examine the iron status in these patients by MRI and by screening for...
What is the current status of trial NCT00806715?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2007-02. Estimated completion is 2010-10.
Who is sponsoring clinical trial NCT00806715?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia